title: Prevalence of multidrug-resistant, methicillin-resistant Staphylococcus aureus in the United States: findings of the stratified analysis of the 2004 to 2005 LEADER Surveillance Programs.
abstract: Surveillance data for methicillin-resistant Staphylococcus aureus (MRSA) and multidrug resistance (MDR) among MRSA were analyzed by patient location and age. MRSA rates were 55.7% among inpatients (53.9% MDR) and 48.7% among outpatients (30.7% MDR), with MDR rates increasing with age. These findings could impact the guidelines for the management and treatment of staphylococcal infections.
authors.affiliation: Eurofins Medinet Anti-infective Services, Herndon, VA 20171-4603, USA.
authors.forename: Chris M
authors.initials: CM
authors.lastname: Pillar
authors.forename: Deborah C
authors.initials: DC
authors.lastname: Draghi
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Sheehan
authors.forename: Daniel F
authors.initials: DF
authors.lastname: Sahm
mesh_terms: D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D007297:Inpatients; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D010045:Outpatients; D015995:Prevalence; D013203:Staphylococcal Infections / Q000453:epidemiology / Q000382:microbiology*; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification; D014481:United States / Q000453:epidemiology
chemical_list: D000900:Anti-Bacterial Agents